This suggests that different transcripts could be involved in the different expression patterns obtained with the two antibodies used, as previously reported in human breast cancers, which also presented a statistically significant correlation between ERBB2 mRNA RT-qPCR and protein IHC expression levels [71], [72]. Here, ERBB2 is linked to breast carcinoma.